Empagliflozin: a path from glycemic control to reduced cardiovascular mortality and heart failure-related hospitalizations

Empagliflozin: a path from glycemic control to reduced cardiovascular mortality and heart failure-related hospitalizations

In the EMPA-REG OUTCOME, CANVAS and DECLARE-TIMI 58 studies, in patients with type 2 diabetes and established cardiovascular diseases or risk factors, a decrease in the risk of cardiovascular events and development or worsening of heart failure course without an increase in hypoglycemia incidence wa...

Full description

Saved in:

Bibliographic Details
Main Author:	N. R. Khasanov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-02-01
Series:	Российский кардиологический журнал
Subjects:	heart failure reduced left ventricular ejection fraction effects of sodium-glucose co-transporter-2 inhibitors empagliflozin
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4807
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2018-05-01)

Twenty-four-year-old patient with heart failure after myocarditis. Results of quadruple therapy: a case report
by: V. N. Larina, et al.
Published: (2023-04-01)

Management of Patients with Chronic Heart Failure and Diabetes Mellitus
by: E. V. Reznik, et al.
Published: (2021-05-01)

Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study
by: A. G. Ovchinnikov, et al.
Published: (2021-02-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan
by: José-Manuel Rubio-Campal, et al.
Published: (2025-06-01)

Coronary Artery Disease Is A Stronger Predictor of All‐Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR
by: Roni Ranghoej Nielsen, et al.
Published: (2024-07-01)

Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study
by: Abdullahi Ahmed Mohamed, et al.
Published: (2025-08-01)

Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I
by: Yu. M. Lopatin, et al.
Published: (2021-05-01)

Incidence of Rapid Rate Non‐Sustained and Sustained Ventricular Tachycardia in Implantable Cardioverter‐Defibrillator Recipients and Its Correlation With Heart Failure Guideline‐Directed Medical Therapy Compliance
by: Muhammad Taha Khan, et al.
Published: (2025-08-01)

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
by: I. V. Zhirov, et al.
Published: (2021-02-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Risk Factors Influencing Right and Left Ventricular Variables Assessed with Gated Cadmium–Zinc–Telluride Equilibrium Radionuclide Angiocardiography in Oncology Patients
by: Olav Monsson, et al.
Published: (2025-05-01)

Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
by: Mathilde Berger, et al.
Published: (2020-04-01)

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
by: Maria del Carmen Asensio-Lopez, et al.
Published: (2025-04-01)

Heart Failure with Preserved Ejection Fraction in the Indian Context
by: Rajeev Gupta, et al.
Published: (2025-04-01)

Different Modes of Monitoring and Correction of Cardiac Function During Operations Under Extracorporeal Circulation
by: L. A. Krichevsky, et al.
Published: (2007-02-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor
by: D. A. Lebedev, et al.
Published: (2020-10-01)

Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease
by: Qingkuan Li, et al.
Published: (2025-07-01)

Medication adherence in patients with heart failure: a pilot observational study in outpatient practice
by: V. N. Larina, et al.
Published: (2024-12-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Predictors of sustained reverse remodelling in patients with heart failure with reduced ejection fraction
by: Silas Ramos Furquim, et al.
Published: (2025-06-01)

Dynamics of chronic heart failure with a low ejection fraction when dapagliflozin is included in standard therapy
by: A. A. Tsareva, et al.
Published: (2024-04-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling
by: Gwo‐Jyh Chang, et al.
Published: (2024-11-01)

Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
by: E. V. Kovalenko, et al.
Published: (2021-02-01)

Prevalence of anemia, its associated factors, and impact on quality of life among heart failure with reduced ejection fraction outpatients at the university of Gondar hospital, Ethiopia
by: Daniel Belay Agonafir, et al.
Published: (2025-07-01)

ARTERIAL STIFFNESS IN CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Empagliflozin reduces liver fibrosis by restoring catechol-O-methyltransferase activity associated with magnesium levels
by: Yoshihiro Hayashi, et al.
Published: (2025-07-01)

Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure
by: A. M. Alieva, et al.
Published: (2023-01-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II
by: S. V. Nedogoda, et al.
Published: (2022-03-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts
by: A. S. Galyavich, et al.
Published: (2022-02-01)

Coronary artery pathology and left ventricular ejection fraction changes in patients with primary non-Q wave myocardial infarction
by: V. V. Krylov, et al.
Published: (2008-06-01)

Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction
by: Roman Falls, et al.
Published: (2025-06-01)

Two-year follow-up of patients with heart failure with reduced ejection fraction receiving cardiac contractility modulation
by: M. A. Vander, et al.
Published: (2020-08-01)

Efficacy of alpha-lipoic acid in patients with ischemic heart failure: a randomized, double-blind, placebo-controlled study
by: Hanchuan CHEN, et al.
Published: (2025-08-01)

Adverse effects of intracardiac dyssynchrony and right ventricular pacing on contractile function and prognosis
by: D. Yu. Andreev, et al.
Published: (2025-02-01)